Search Results - "van Schie, Rianne M.F"

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon by Verhoef, Talitha I, Ragia, Georgia, de Boer, Anthonius, Barallon, Rita, Kolovou, Genovefa, Kolovou, Vana, Konstantinides, Stavros, Le Cessie, Saskia, Maltezos, Efstratios, van der Meer, Felix J.M, Redekop, William K, Remkes, Mary, Rosendaal, Frits R, van Schie, Rianne M.F, Tavridou, Anna, Tziakas, Dimitrios, Wadelius, Mia, Manolopoulos, Vangelis G, Maitland-van der Zee, Anke H

“…A genotype-guided dosing algorithm was compared with a clinical dosing algorithm in patients starting anticoagulation with acenocoumarol or phenprocoumon…”
Get full text

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data by van Schie, Rianne M.F., Wessels, Judith A.M., le Cessie, Saskia, de Boer, Anthonius, Schalekamp, Tom, van der Meer, Felix J.M., Verhoef, Talitha I., van Meegen, Erik, Rosendaal, Frits R., Maitland-van der Zee, Anke-Hilse

“…Aims Polymorphisms in CYP2C9 and VKORC1 influence patients' phenprocoumon (PHE) and acenocoumarol (ACE) dose requirements. To provide physicians with tools to…”
Get full text

Pharmacogenetic‐guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon by Verhoef, Talitha I., Redekop, William K., Daly, Ann K., Schie, Rianne M. F., Boer, Anthonius, Maitland‐van der Zee, Anke‐Hilse

“…Coumarin derivatives, such as warfarin, acenocoumarol and phenprocoumon are frequently prescribed oral anticoagulants to treat and prevent thromboembolism…”
Get full text

Immunological Risk of Injectable Drug Delivery Systems by Jiskoot, Wim, van Schie, Rianne M. F., Carstens, Myrra G., Schellekens, Huub

“…Injectable drug delivery systems (DDS) such as particulate carriers and water-soluble polymers are being used and developed for a wide variety of therapeutic…”
Get full text

Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users by Verhoef, Talitha I., Redekop, W. Ken, Bouvy, Marcel L., Dorenbos, Brenda, Karwar, Zamiera, Schie, Rianne M. F., Boer, Anthonius, Maitland‐van der Zee, Anke‐Hilse

“…Aims Adherence to the generally complex regimen of coumarin derivatives is vital in order to keep patients in the adequate International Normalized Ratio…”
Get full text

Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation by Verhoef, Talitha I, Redekop, William K, Veenstra, David L, Thariani, Rahber, Beltman, Peter A, van Schie, Rianne Mf, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

“…To investigate the cost-effectiveness of pharmacogenetic-guided phenprocoumon dosing versus standard anticoagulation care in Dutch patients with atrial…”
Get more information

Corrigendum to: ‘Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data’ [Eur Heart J (2011) 32 (15): 1909-1917, doi:10.1093/eurheartj/ehr116] by van Schie, Rianne M.F., Wessels, Judith A.M., le Cessie, Saskia, de Boer, Anthonius, Schalekamp, Tom, van der Meer, Felix J.M., Verhoef, Talitha I., van Meegen, Erik, Rosendaal, Frits R., Maitland-van der Zee, Anke-Hilse

Get full text

Implementation of pharmacogenetics in clinical practice is challenging by van Schie, Rianne M F, de Boer, Anthonius, Maitland-van der Zee, Anke Hilse

Get more information

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design by van Schie, Rianne M F, Wadelius, M I A, Kamali, Farhad, Daly, Ann K, Manolopoulos, Vangelis G, de Boer, Anthonius, Barallon, Rita, Verhoef, Talitha I, Kirchheiner, Julia, Haschke-Becher, Elisabeth, Briz, Montserrat, Rosendaal, Frits R, Redekop, William K, Pirmohamed, Munir, Maitland van der Zee, Anke-Hilse

“…The narrow therapeutic range and wide interpatient variability in dose requirement make anticoagulation response to coumarin derivatives unpredictable. As a…”
Get more information

The effect of omeprazole and esomeprazole on the maintenance dose of phenprocoumon by Verhoef, Talitha I., Zuurhout, Miranda J. L., van Schie, Rianne M. F., Redekop, William K., van der Meer, Felix J. M., le Cessie, Saskia, Schalekamp, Tom, de Boer, Anthonius, Maitland‐van der Zee, Anke Hilse

Get full text

Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original study by van Schie, Rianne M F, el Khedr, Nadia, Verhoef, Talitha I, Teichert, Martina, Stricker, Bruno H, Hofman, Albert, Buhre, Peter N, Wessels, Judith A M, Schalekamp, Tom, le Cessie, Saskia, van der Meer, Felix J M, Rosendaal, Frits R, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse, Visser, Loes E

“…To evaluate the performance of the European Pharmacogenetics of Anticoagulant Therapy (EU-PACT) acenocoumarol dose algorithms in an independent data set. The…”
Get more information

Evaluation of the effect of genetic variations in GATA-4 on the phenprocoumon and acenocoumarol maintenance dose by van Schie, Rianne M F, Wessels, Judith A M, Verhoef, Talitha I, Schalekamp, Tom, le Cessie, Saskia, van der Meer, Felix J M, Rosendaal, Frits R, Visser, Loes E, Teichert, Martina, Hofman, Albert, Buhre, Peter N M, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

“…To investigate whether the phenprocoumon and acenocoumarol maintenance doses are influenced by genetic variations in GATA-4, a transcription factor of CYP2C9…”
Get more information

Systematic Review of Pharmacogenetic Warfarin Dosing by van Schie, Rianne M. F., Jorgensen, Andrea L., de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

Get full text

Conference Scene: Pharmacogenomics at the second PharmSciFair 2009: adverse drug reactions and clinical implementation by van Schie, Rianne M F, Cascorbi, Ingolf, Maitland-van der Zee, Anke Hilse

“…From 8th to 12th June 2009, the second PharmSciFair took place in Nice, France. Sessions were organized on different types of pharmaceutical research. Two…”
Get more information

Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose by van Schie, Rianne M F, Verhoef, Talitha I, Boejharat, Saskia B, Schalekamp, Tom, Wessels, Judith A M, le Cessie, Saskia, Rosendaal, Frits R, van der Meer, Felix J M, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

“…Statins and coumarins are prescribed in combination on a regular basis. Some case reports suggested that statins might affect the dose requirements of…”
Get more information